In order to further explore the mechanism of AR in the treatment of lung cancer, except for the p53, p-Bcl-2 and mTOR, the expression of other molecules downstream of the PI3K-Akt signaling pathway was explored, including AMPK and Beclin1. The gene discussed is PIK3CB; the disease is lung cancer.